Clinical Trial Update: Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating Furoscix for reducing hospital admissions in heart failure, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furoscx (furosemide)

Snippet

Sponsor: scPharmaceuticals, Inc. | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2023-02-24